FAS ligand derived polypeptides
AssigneesMochida Pharmaceutical Co., Ltd., Osaka Bioscience Institute
InventorsShigekazu Nagata, Takashi Suda, Tomohiro Takahashi, Norio Nakamura
Life of this patent
Estimating the term…
Loading patent…
AssigneesMochida Pharmaceutical Co., Ltd., Osaka Bioscience Institute
InventorsShigekazu Nagata, Takashi Suda, Tomohiro Takahashi, Norio Nakamura
Estimating the term…
This invention provides a polypeptide useful in the field of medicines, a DNA which encodes the novel polypeptide, a recombinant DNA molecule which contains the DNA, a transformant transformed with the DNA or the recombinant DNA molecule, a process for the purification of the polypeptide, a process for the production of the polypeptide, an antibody which recognizes the polypeptide, an oligonucleotide complementary to the DNA and a screening method. Particularly this invention provides a polypeptide, which is Fas ligand or a fragment thereof. This polypeptide can be used as an effective ingredient of a medicament for regulating the apoptosis in a living body. This polypeptide is obtained by identifying a DNA fragment, which encodes the polypeptide, transforming a desired host with a recombinant DNA molecule, which contains the DNA fragment, and purifying the polypeptide produced by the resulting transformant. This polypeptide has a cytoplasmic domain, a transmembrane domain and extracellular domain and takes part in apoptosis.
An isolated polypeptide selected from the group consisting of:
Dependencies are inferred from the claim text.